ABDSEROTEC search AbDSerotec TP53 products
includes other brands or spellings
|
| wb | | Serotec polyclonal anti-p53 antibody (clone Pab 240) was used in protein from human prostate and in western blot to study the expression of EG-VEGF/PK1 and PK2 and their receptors (PK-R1 and PK-R2) in human prostate and their involvement in cancer. |
CELL SIGNALING TECHNOLOGY search Cell Signaling Technology TP53 products
includes other brands or spellings
|
| ic, wb | | Cell Signaling anti-phospho-p53 (Ser-15) antibody was used in western blot and immunocytochemistry to investigate the induction of DNA damage checkpoint signal transduction by herpes simplex virus. |
| ih, wb | | Cell Signaling anti-phospho-p53 Ser15 antibody was used in western blot and immunohistochemistry to study the down-regulation of constitutive and UVB-induced COX-2 levels by T-oligo treatment through p53- and NFkappaB-dependent repression of the COX-2 promoter. |
| ip | | Cell Signaling rabbit polyclonal antibodies against phospho-Ser15 p53 and total p53 were used in immunoprecipitation to study the role of p53-nucleolin complex to mediate stress-dependent nucleolin mobilization. |
| wb | | Cell Signaling Phospho-p53 (Ser15) 16G8 mAb antibody was tested in western blot by Abminer. |
| wb | | Cell Signaling anti-phospho-p53 Ser15 antibody was used in western blot to study the regulation of human Rif1, ortholog of a yeast telomeric protein by ATM and 53BP1 and its function in the S-phase checkpoint. |
| wb | | New England Biolabs polyclonal anti-p53 antibody was used in western blot to study the role of disialoganglioside (GD3) synthase gene to suppress vascular smooth muscle cell (VSMC) responses via the inhibition of ERK1/2 phosphorylation, cell cycle progression, and matrix metalloproteinase-9 expression. |
| wb | | Cell Signaling anti-phospho-p53 polyclonal antibodies were used in western blot to study the role of phosphorylation and hsp90 binding in stabilizing p53 after heat shock. |
| wb | | Cell Signaling Technology anti-p53 and phospho-p53 antibody was used in western blot to study that resveratrol increases serine15-phosphorylated but transcriptionally impaired p53 and induces a reversible DNA replication block in serum-activated vascular smooth muscle cells. |
| wb | | Cell Signaling anti-p53 phospho-Ser15 (16G8) and anti-p53 phospho-Ser20 antibodies were used in human cells and in western blot to study the effect of human PTIP on ATM-mediated activation of p53 and cellular resistance to ionizing radiation. |
| wb | | Cell Signaling Technology anti-phospho-p53 (p-p53) (Ser15) antibody (9284) was used in human mesenchymal stem cells (hMSCs) and in western blot to study the prolongation of life span of human umbilical cord blood-derived mesenchymal stem cells (UCBMSCs). |
| wb | | Cell Signaling antiphospho-p53 Ser-20 polyclonal antibody was used in western blot to study the role of the promyelocytic leukemia protein to protect p53 from Mdm2-mediated inhibition and degradation. |
| wb | | New England Biolabs anti-phospho-Ser-15 p53 antibody was used in western blot to study the role of p53 to repress cyclin D1 transcription through down regulation of Bcl-3 and inducing increased association of the p52 NF-kappaB subunit with histone deacetylase 1. |
| wb | | Cell Signaling Technology rabbit polyclonal anti-phospho-p53 (Ser37, Ser15, Ser20) antibodies were used in western blot to study the modulation of p53, ErbB1, ErbB2, and Raf-1 expression in lung cancer cells by depsipeptide FR901228. |
| wb | | Cell Signaling anti-p53 antibody was used in western blot to investigate the role of ORC2 in CDK2 activation. |
| wb | | Cell Signaling Technology phospho-p53 antibody was used in western blot to study the effect of human p53 serine 46 phosphorylation on promoter selection and apoptosis. |
SANTA CRUZ BIOTECHNOLOGY search Santa Cruz Biotechnology TP53 products
includes other brands or spellings
|
| chip, ih, wb | | Santa Cruz Biotechnology polyclonal anti-p53 antibody was used in western blot, immunohistochemistry and ChIP assay to study p53 in T47D cells or MCF7 breast carcinoma cells. |
| chip, wb | | Santa Cruz anti-p53 (DO.1, Pab-240, FL-393-G) antibodies were used in western blot and Santa Cruz anti-p53 (FL-393-G) antibody was used in ChIP assay to study the regulation of p53 protein levels and activity by PTEN tumor suppressor through phosphatase-dependent and -independent mechanisms. |
| chip, wb | | SCBT anti-p53 antibody was used in western blot and ChIP assays to investigate the regulation of death receptor 5 expression by NFKB1. |
| elisa, wb | | Santa Cruz Biotechnology monoclonal anti-p53 antibody Bp53-12 was used in western blot and ELISA to study the p53-induced Gene-6 (proline oxidase) which mediates apoptosis through a calcineurin-dependent pathway. |
| flow | | Santa Cruz Biotechnology fluorescein isothiocyanate-conjugated anti-p53 antibody was used in flow cytometry to study the role of UCN-01 in checkpoint regulation. |
| ic, ih, ip, wb | | SCBT monoclonal mouse anti-human p53-DO-1 (p53-DO-1) antibody was used in immunohistochemistry, immunocytochemistry, western blot, and immunoprecipitation, and monoclonal mouse anti-human p53-1801 (p53-1801) antibody was used in immunohistochemistry to study the interaction between calcium-binding protein S100A2 and p53. |
| ic, ip, wb | | Santa Cruz Biotechnology anti-p53 antibody DO1, goat anti-p53 antibody FL393 and rabbit anti-p53 antibody FL293 were respectively used in immunoprecipitation, western blot and immunocytochemisty to study the effect of 14-3-3 on p53 and tumor growth. |
| ic, ip, wb | | SCBT monoclonal anti-p53 DO-1 antibody was used in western blot, immunoprecipitation, and immunocytochemistry to investigate the regulation of p53 by GSK through MDM2. |
| ic, wb | | SCBT anti-p53 antibody (DO-1) was used in western blot and immunocytochemistry to investigate the interaction between SMN1 and p53. |
| ih, wb | | Santa Cruz Biotechnology monoclonal anti-p53 antibodies DO-1 and FL-293 were respectively used in HCT116 colon carcinoma cells, H1299 lung adenocarcinoma cells and paraffin sections from wounded skin, and which were respctively used in western blot and immunohistochemistry, to study the roles for tumor suppressor p53 and its homologue p73 in cell migration. |
| ih | | Santa Cruz Biotechnology anti-p53 antibody was used in immunohistochemistry to study the associativity of expression of thrombospondin-1 and osteopontin with absence or presence metastatic phenotype in an isogenic model of spontaneous human breast cancer metastasis. |
| ih | | Santa Cruz Biotechnology mouse monoclonal anti-carboxy terminus of p53 (clone sc-263) antibody was used in immunohistochemistry to study expression of secreted frizzled receptor protein 1 in patients with hyperplastic polyposis coli syndrome.. |
| ip, wb | | Santa Cruz Biotechnology monoclonal anti-p53 antibody DO-1 was used in human RKO colorectal carcinoma cells and in western blot, immunoprecipitation to study the role for HuR in binding to the p53 mRNA and enhancing its translation. |
| ip, wb | | Santa Cruz Biotechnology anti-p53 monoclonal antibody was used in western blot and immunoprecipitation to detect p53 expression in 786-O, UOK121 and UMRC6 renal cell carcinoma (RCC) cells. |
| ip, wb | | Santa Cruz Biotechnology murine monoclonal anti-p53 (DO-1) and goat polyclonal anti-p53 antibodies were used in immunoprecipitation and western blot to study expression of p53, ErbB1, ErbB2, and Raf-1 in lung cancer. |
| ip | | Santa Cruz Biotechnology anti-p53 antibody was used in human HCT116 cells and in immunoprecipitation to study the role for FAT10 in the regulation of chromosomal stability. |
| wb | | Santa Cruz anti-p53 (DO-1) antibody was used in western blot to study the regulation of human Rif1, ortholog of a yeast telomeric protein, by ATM and 53BP1 and its function in the S-phase checkpoint. |
| wb | | Santa Cruz Biotechnology anti-p53 antibody SC-126 was used in western blot to study the effect of p53-independent NOXA induction on apoptotic resistance of malignant melanomas. |
| wb | | Santa Cruz Biotechnology mouse monoclonal anti-p53 antibody (DO-1) was used in western blot to study the effec of activated m-Calpain on chromosome alignment on the metaphase plate during mitosis. |
| wb | | Santa Cruz Biotechnology anti-human p53 antibody was used in western blot to detect p53 in the HCT116 cell transfected with RET/PTC3. |
| wb | | Santa Cruz Biotechnology monoclonal anti-p53 antibody DO-1 was used in human T-cell lymphoblastic leukemia cell line CCRF-HSB-2 cells and in western blot to study the taxol-induced caspase-10-dependent apoptosis. |
| wb | | Santa Cruz Biotechnology rabbit polyclonal anti-p53 antibody (FL-393) was used in COS-7 cells and in western blot to study the differences of effects of ik3-1/cables on p53- and p73-induced cell death. |
| wb | | Santa Cruz Biotechnology mouse monoclonal anti-p53 antibodies (sc-99 or sc-126) was used in Chinese hamster CHO-OX1 cells with human OX1 receptors and in western blot to study the role of G-protein-coupled receptor signaling in cell death via p38 mitogen-/stress-activated protein kinase independent of p53 and caspase activation. |
| wb | | Santa-Cruz antibody against p53 (sc-26/clone DO1) was used in western blot to study the replicative senescence triggered by DNA damage checkpoint kinase Chk2. |
| wb | | SCBT anti-p53 antibody (DO-1) was used in western blot to investigate the regulation of Cdc6 protein stability by p53. |
| wb | | SCBT anti-p53 DO-1 antibody was used in western blot to investigate the decrease of COX-2 Levels through p53 and NFkB by T-oligo. |
| wb | | Santa Cruz monoclonal p53 antibody (DO-1) was used in western blot to study the mechanism by which WISP-1 promotes tumorigenicity. |
| wb | | Santa Cruz Biotechnology anti-p53 antibody was used in western blot to study the effects of UVB irradiation on cell cycle and apoptosis markers. |
| wb | | SCBT anti-p53 (FL393) and anti-p53 (DO-1) antibodies were used in western blot to study the induction of neuroblastoma cell apoptosis by TrkA. |
| wb | | Santa Cruz Biotechnology monoclonal anti-p53 antibody (DO-1) was used in western blot to study a physiological role of hGTSE-1 in apoptosis control after DNA damage during S and G2 phases through regulation of p53 function.. |
| wb | | Santa Cruz mouse monoclonal antibody DO-1 against total p53 was used in western blot to study the stress-dependent nucleolin mobilization mediated by p53-nucleolin complex formation. |
| wb | | SCBT rabbit polyclonal anti–human p53 antibody was used in western blot to study the apoptosis in p53-defective tumors. |
| wb | | Santa Cruz Biotechnology Inc p53 antibody was used in western blot to study the effect of human p53 serine 46 phosphorylation on promoter selection and apoptosis. |
| wb | | Santa Cruz p53 antibody was used in western blot to study p130/p107/p105Rb-dependent transcriptional repression during DNA-damage-induced cell-cycle exit at G2. |
EMD BIOSCIENCES search EMD Biosciences TP53 products
includes other brands or spellings
|
| emsa, wb | | Calbiochem anti-p53 monoclonal antibody was used in western blot and EMSA to study the phosphatase MKP1 as a transcriptional target of p53 involved in cell cycle regulation. |
| ic, ih | | Oncogene Science monoclonal anti-p53 antibody Pab 1801 (which recognized epitopes between amino acids 32 to 79) and monoclonal anti-p53 antibody DO-1 (which recognized epitopes between amino acids 17 to 26) were used in paraffin sections from human tumors and SH-SY5Y cells, which were respectively used in immnohistochemistry and immunocytochemistry, to study the role for the p73 gene in human neuroblastic tumors. |
| ic, ip, wb | | Oncogene monoclonal anti-p53 Ab-2 antibody was used in western blot, immunoprecipitation, and immunocytochemistry to study the regulation of p53 abundance through glycogen synthase kinase 3-dependent phosphorylation of Mdm2. |
| ic, wb | | Oncogene Science mouse anti-human p53 monoclonal antibody (Ab-6) was used in western blot and Oncogene Science sheep anti-human p53 polyclonal antibody Ab-7 was used in immunocytochemistry to study the induction of p53-dependent BRCA1 nuclear export by DNA damage. |
| ic, wb | | Oncogene anti-p53 (Ab-6) antibody was used in western blot and immunocytochemistry to investigate the induction of DNA damage checkpoint signal transduction by herpes simplex virus. |
| ih | | Oncogene anti-p53 antibody clone BP53.12.1 was used in paraffin sections from human urothelial bladder carcinomas and in immunohistochemistry to study the role of TIMP-2 in human urothelial cancer. |
| ih | | Oncogene Research Products mouse monoclonal anti-human p53 antibody (PAb1801 clone, which recognizes an epitope located between amino acids 46 and 55) was used in paraffin sections from normal human tissues, papillary superficial tumors, invasive lesions and in immunohistochemistry to study the expression profile of p73 in human normal tissues and the correlation between p73 expression and bladder cancer progression. |
| ih | | Oncogene Science monoclonal mouse anti-serum against p53 of human origin antibody Ab-6 (which recognizes both wild-type and mutant p53) was used in paraffin sections from human gastric precancerous and cancerous lesions and in immunohistochemistry to study the correlation of expression of p53, VEGF and iNOS and clinical features in gastric carcinogenesis. |
| ih | | Oncogene anti-p53 (clone DO1) monoclonal antibody was used in immunohistochemistry to study p53, mdm2, EGFR, and msh2 expression in paired initial and recurrent glioblastoma multiforme. |
| ih | | Oncogene Research Products polyclonal anti-p53 antibody (PAb1801) was used in immunohistochemistry to study the correlation of the expression of a panel of oncogenic proteins (Bcl-2, Bcl-6, and c-Myc) and p53 with the overall survival of immunocompetent individuals with primary CNS DLBCL. |
| ip, wb | | Oncogene Science anti-p53 antibody DO1 was used in immunoprecipitation and western blot to study the effect of 14-3-3 on p53 and tumor growth. |
| ip, wb | | Oncogene Research monoclonal anti-p53 antibody (DO-1) was used in western blot and immunoprecipitation to study the biological function of protein kinase A catalytic subunit beta. |
| ip, wb | | Oncogene Science murine monoclonal anti-p53 antibodies (DO-1 and PAb421) were used in H1299 cells and in western blot, immunoprecipitation to study the role of TA-p73 expression for tumor formation. |
| wb | | Oncogene Science mouse anti-p53 antibody was used in western blot to study the induction of extracellular matrix-remodeling genes by the senescence-associated protein APA-1. |
| wb | | Calbiochem monoclonal anti-human p53 antibody DO-1 was used in western blot to study the effect of p73β on p57KIP2 expression. |
| wb | | Oncogene Research Products monoclonal anti-p53 antibody (DO-1) was used in COS7 cells and in western blot to study the interaction of p73 with c-Myc and MM1, a c-Myc-binding protein and the effect of it on the p73 function. |
| wb | | Oncogene Science anti-p53 antibody DO-1 was used in human mesenchymal stem cells (hMSCs) and in western blot to study the prolongation of life span of human umbilical cord blood-derived mesenchymal stem cells (UCBMSCs). |
| wb | | Oncogene mouse anti-human p53 (Ab-1, OP03) was used in western blot to study the function of the heparin-binding domain and V region of fibronectin to regulate apoptosis by suppression of p53 and c-myc in human primary cells. |
| wb | | Oncogene Research Products rabbit polyclonal anti-acetylated-p53 antibody was used in western blot to study the modulation of p53, ErbB1, ErbB2, and Raf-1 expression in lung cancer cells by depsipeptide FR901228. |
| wb | | Oncogene Research Products mouse monoclonal anti-p53 antibody (Ab-6) was used in western blot to study the selective induction of apoptosis by synthetic retinoid CD437 in human lung cancer cells. |
| wb | | Oncogene Sciences mouse monoclonal anti-p53 antibody (Ab-2) was used in western blot to study the role of silenced p53 target gene snk/plk2 in leading to mitotik catastrophe in paclitaxel (taxol) -exposed cells. |
| wb | | Calbiochem anti-p53 (Ab6) antibody was used in western blot to study the molecular basis of p53 functional inactivation by the leukemic protein MLL-ELL. |
| wb | | Calbiochem polyclonal anti-p53 antibody Ab-7 was used in western blot to study interactions of the tumor suppressor protein p53 and DNA polymerase alpha-primase. |
BD BIOSCIENCES search BD Biosciences TP53 products
includes other brands or spellings
|
| ic | | BD Transduction Laboratories mouse monoclonal p53 antibody was used in immunocytochemistry to characterize the interaction between RanBP2 and Ubc9. |
| ip, wb | | BD PharMingen anti–human p53 antibody (DO-7) was used in western blot to detect the mutant p53 in mouse lung adenocarcinomas and normal mouse lung tissue, and in immunoprecipitation to isolate mutant and wild-type p53 from mouse tumors and matched normal lung tissues. |
| wb | | BD Transduction p53 antibody was tested in western blot by Abminer. |
| wb | | Pharmingen p53 antibody was tested in western blot by Abminer. |
| wb | | BD Biosciences anti-p53 antibody and anti-phosphorylated p53 antibody were used in western blot to study the function of Frag1 protein in higher eukaryotes. |
MILLIPORE search Millipore TP53 products
includes other brands or spellings
|
| wb | | Upstate Biotechnology p53 antibody was used in western blot to study the side effect of methylglyoxal in enhancing cisplatin-induced cytotoxicity by activating protein kinase Cdelta. |
| wb | | Upstate Biotechnology anti-acetyl p53 (Lys 373 and Lys 382) antibody was used in western blot to study the molecular basis of p53 functional inactivation by the leukemic protein MLL-ELL. |
| wb | | Upstate p53 antibody was used in western blot to investigate the effect of chloramphenicol-induced mitochondrial stress on p21 expression and cell apoptosis. |
THERMO FISHER SCIENTIFIC search Thermo Fisher Scientific TP53 products
includes other brands or spellings
|
| wb | | Lab Vision p53 antibody was tested in western blot by Abminer. |
| wb | | NeoMarkers anti-p53 antibody was used in human T-cell leukemia cell lines and in western blot to study the effect of Jak-Stat pathway on cell growth of human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells. |
BECKMAN COULTER search Beckman Coulter TP53 products
includes other brands or spellings
|
| ih, wb | | Dako anti-p53 DO-7 antibody was used in western blot and immunohistochemistry to study the down-regulation of constitutive and UVB-induced COX-2 Levels by T-oligo treatment through p53- and NFB-dependent repression of the COX-2 promoter. |
| ih | | DAKO anti-p53 DO7 antibody was used in immunohistochemistry to study the pathology of ovarian cancers in BRCA1 and BRCA2 carriers. |
| ih | | DAKOCytomation anti-p53 antibody was used in immunohistochemistry to study the association of the loss of expression of the adipocyte-type fatty acid-binding protein (A-FABP) with progression of human urothelial carcinomas. |
| ih | | DAKO monoclonal anti-p53 antibody was used in immunohistochemistry to study the role of overexpression of macrophage migration inhibitory factor gene and protein for angiogenesis in glioblastoma multiforme. |
| ih | | DAKO mouse monoclonal anti-p53 DO-7 antibody was used in immunohistochemistry to study the predictive significance of the alterations of p16INK4A, p14ARF, p53, and proliferating cell nuclear antigen expression in the progression of cervical cancer. |
| ih | | DAKO anti-p53 antibody was used in immunohistochemistry to detect p53 in normal lung, benign lesions, preinvasive lesions, low-grade tumors and invasive lung carcinoma. |
| ih | | DAKO monoclonal anti-p53 antibody (clone DO-1) was used in paraffin sections from human and in immunohistochemistry to study the role for aberrant Wnt/ß-catenin pathway activation in idiopathic pulmonary fibrosis. |
| ih | | DAKO monoclonal anti-p53 DO7 antibody was used in immunohistochemistry to study the reduced dystroglycan expression in human breast and colon cancers and the possible association with tumor progression. |
| ih | | DAKO A/F anti-TP53 (DO-7) antibody was used in immunohistochemistry to study translocation, deletion/amplification, and expression of HMGIC and MDM2 in a carcinoma ex pleomorphic adenoma. |
| wb | | DAKO mouse monoclonal antiserum against human p53 (DO-7) was used in western blot to study the role of p38 kinase in hypoxia-inducible factor 1-independent induction of vascular endothelial growth factor expression by sodium arsenite. |
| wb | | DAKO monoclonal anti-p53 antibody DO-7 was used in western blot to study the Np73-mediated transactivation of the BTG2TIS21/PC3 gene. |
| wb | | Dako anti-p53 (DO-7) monoclonal antibody was used in western blot to study the role of shox in cell cycle, apoptosis and human growth plate chondrocytes. |
| wb | | DAKO p53-specific DO-7 monoclonal antibody was used in western blot to study the lck degradation and refractory state in CD8+ cytotoxic T lymphocytes. |
LEICA MICROSYSTEMS search Leica Microsystems TP53 products
includes other brands or spellings
|
| ih | | Novocastra mouse anti-p53 monoclonal antibody was used in immunohistochemistry to study the frequent co-Localization of cox-2 and laminin-5 2 chain at the invasive front of early-stage lung adenocarcinomas. |
| ih | | Novocastra Laboratories mouse monoclonal anti-human p53 antibody NCL-p53-DO7 was used in paraffin sections from human hepatocellular carcinoma and in immunohistochemistry to study the association between growth arrest DNA damage-inducible gene 45ß expression and human hepatocellular carcinoma. |
| ih | | Novocastra Laboratories p53 antibody (DO-7) was used in immunohistochemistry to study the biological features of MLH1 expression during CDDP-based chemotherapy. |
| ih | | NovoCastra anti-p53 antibody (clone DO7) was used in tissue sections from human and in immunohistochemistry to study the cell cycle regulation in patients with IM at the GOJ. |
| ip | | Novacastra Laboratories anti-p53 antibody was used in immunoprecipitation to study the interaction of HPV 16 E6 with TNF R1 in U2OS cells stably expressing HA-E6. |
| wb | | Novocastra antibody which recognizes human p53 was used in western blot to study that p400 is required for E1A to promote apoptosis. |
| wb | | Novocastra anti-p53 antibody (DO-7) was used in human cells and in western blot to study the effect of human PTIP on ATM-mediated activation of p53 and cellular resistance to ionizing radiation. |
| wb | | Novocastra mouse monoclonal anti-p53 antibody (NCL-p53-DO7) was used in human fibroblasts and in western blot to study the expression of the mutated BRCA2 gene in BRCA2 999del5 heterozygous cells and the functional consequences of BRCA2 999del5 at the cellular level. |
ROCHE APPLIED SCIENCE search Roche Applied Science TP53 products
includes other brands or spellings
|
| elisa | | Roche Molecular Biochemicals biotinylated anti-p53 antibody was used in ELISA to detect the level of p53 in U2OS cells transfected with either sense or antisense versions of epitope-tagged HA-E6. |
NEOMARKERS BIOTECHNICAL COMPANY
|
| ih | | Neomarkers Biotechnical Company mouse monoclonal anti-human p53 antibody was used in immunohistochemistry to detect p53 in colon cancer tissues. |
NOVOCASTRA
|
| ih | | Novocastra mouse anti-p53 monoclonal antibody was used in immunohistochemistry to study the frequent co-Localization of cox-2 and laminin-5 2 chain at the invasive front of early-stage lung adenocarcinomas. |
| ih | | NovoCastra anti-p53 antibody (clone DO7) was used in tissue sections from human and in immunohistochemistry to study the cell cycle regulation in patients with IM at the GOJ. |
| wb | | Novocastra antibody which recognizes human p53 was used in western blot to study that p400 is required for E1A to promote apoptosis. |
| wb | | Novocastra anti-p53 antibody (DO-7) was used in human cells and in western blot to study the effect of human PTIP on ATM-mediated activation of p53 and cellular resistance to ionizing radiation. |
| wb | | Novocastra mouse monoclonal anti-p53 antibody (NCL-p53-DO7) was used in human fibroblasts and in western blot to study the expression of the mutated BRCA2 gene in BRCA2 999del5 heterozygous cells and the functional consequences of BRCA2 999del5 at the cellular level. |
SANTACRUZ BIOTECHNOLOGY
|
| ic | | SantaCruz Biotechnology anti-pp53 (Ser-20 p53) antibody was used in human cells and in immunocytochemistry to study the role for p21cip/waf1 and p27kip1 in TNF-α-induced inhibition of proliferation in human glioma cells. |
WAKO
|
| ih | | Wako anti-p53 monoclonal antibody was used in immunohistochemistry to study the high prevalence of decreased expression of KAI1 metastasis suppressor in human oral carcinogenesis. |
Articles Reviewed |
| 1. Philip J Young et al. A direct interaction between the survival motor neuron protein and p53 and its relationship to spinal muscular atrophy. 2002 |
| 2. Keitaro Tsuji et al. Differential effect of ik3-1/cables on p53- and p73-induced cell death. 2002 |
| 3. Jonathan P Godbout et al. Methylglyoxal enhances cisplatin-induced cytotoxicity by activating protein kinase Cdelta. 2002 |
| 4. Hisato Saitoh et al. Perturbation of SUMOlation enzyme Ubc9 by distinct domain within nucleoporin RanBP2/Nup358. 2002 |
| 5. Yvonne L Kapila et al. The heparin-binding domain and V region of fibronectin regulate apoptosis by suppression of p53 and c-myc in human primary cells. 2002 |
| 6. Fei Su et al. WISP-1 attenuates p53-mediated apoptosis in response to DNA damage through activation of the Akt kinase. 2002 |
| 7. Virginia Urquidi et al. Contrasting expression of thrombospondin-1 and osteopontin correlates with absence or presence of metastatic phenotype in an isogenic model of spontaneous human breast cancer metastasis. 2002 |
| 8. Eva Röijer et al. Translocation, deletion/amplification, and expression of HMGIC and MDM2 in a carcinoma ex pleomorphic adenoma. 2002 |
| 9. SĂ©tha Douc-Rasy et al. DeltaN-p73alpha accumulates in human neuroblastic tumors. 2002 |
| 10. Ken-ichi Watanabe et al. Physical interaction of p73 with c-Myc and MM1, a c-Myc-binding protein, and modulation of the p73 function. 2002 |
| 11. Thorsten Stiewe et al. Transactivation-deficient Delta TA-p73 inhibits p53 by direct competition for DNA binding: implications for tumorigenesis. 2002 |
| 12. Toshiro Niki et al. Frequent co-localization of Cox-2 and laminin-5 gamma2 chain at the invasive front of early-stage lung adenocarcinomas. 2002 |
| 13. Eva Blint et al. Induction of p57(KIP2) expression by p73beta. 2002 |
| 14. Katsuhiro Uzawa et al. High prevalence of decreased expression of KAI1 metastasis suppressor in human oral carcinogenesis. 2002 |
| 15. Christian Melle et al. Physical and functional interactions of the tumor suppressor protein p53 and DNA polymerase alpha-primase. 2002 |
| 16. Xiaodan Yu et al. Modulation of p53, ErbB1, ErbB2, and Raf-1 expression in lung cancer cells by depsipeptide FR901228. 2002 |
| 17. Maria Filippova et al. The human papillomavirus 16 E6 protein binds to tumor necrosis factor (TNF) R1 and protects cells from TNF-induced apoptosis. 2002 |
| 18. Ethan A Kohn et al. Abrogation of the S phase DNA damage checkpoint results in S phase progression or premature mitosis depending on the concentration of 7-hydroxystaurosporine and the kinetics of Cdc25C activation. 2002 |
| 19. Shi-Yong Sun et al. The synthetic retinoid CD437 selectively induces apoptosis in human lung cancer cells while sparing normal human lung epithelial cells. 2002 |
| 20. Chang Wei Feng et al. Expression of p53, inducible nitric oxide synthase and vascular endothelial growth factor in gastric precancerous and cancerous lesions: correlation with clinical features. 2002 |
| 21. Mihail S Iordanov et al. The UV (Ribotoxic) stress response of human keratinocytes involves the unexpected uncoupling of the Ras-extracellular signal-regulated kinase signaling cascade from the activated epidermal growth factor receptor. 2002 |
| 22. Yaron Daniely et al. Stress-dependent nucleolin mobilization mediated by p53-nucleolin complex formation. 2002 |
| 23. Jennifer A Benanti et al. Induction of extracellular matrix-remodeling genes by the senescence-associated protein APA-1. 2002 |
| 24. Chuangui Wang et al. Phosphorylation and hsp90 binding mediate heat shock stabilization of p53. 2003 |
| 25. Monique C A Duyndam et al. Evidence for a role of p38 kinase in hypoxia-inducible factor 1-independent induction of vascular endothelial growth factor expression by sodium arsenite. 2003 |
| 26. Michael Bacher et al. Up-regulation of macrophage migration inhibitory factor gene and protein expression in glial tumor cells during hypoxic and hypoglycemic stress indicates a critical role for angiogenesis in glioblastoma multiforme. 2003 |
| 27. Chung-Che Chang et al. Expression of p53, c-Myc, or Bcl-6 suggests a poor prognosis in primary central nervous system diffuse large B-cell lymphoma among immunocompetent individuals. 2003 |
| 28. Alessandro Sgambato et al. Dystroglycan expression is frequently reduced in human breast and colon cancers and is associated with tumor progression. 2003 |
| 29. Daniel J Freeman et al. PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms. 2003 |
| 30. Ursula G B Haider et al. Resveratrol increases serine15-phosphorylated but transcriptionally impaired p53 and induces a reversible DNA replication block in serum-activated vascular smooth muscle cells. 2003 |
| 31. Marco Chilosi et al. Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis. 2003 |
| 32. Dong Wook Kim et al. RET/PTC (rearranged in transformation/papillary thyroid carcinomas) tyrosine kinase phosphorylates and activates phosphoinositide-dependent kinase 1 (PDK1): an alternative phosphatidylinositol 3-kinase-independent pathway to activate PDK1. 2003 |
| 33. Martin Monte et al. The cell cycle-regulated protein human GTSE-1 controls DNA damage-induced apoptosis by affecting p53 function. 2003 |
| 34. Anna A Sablina et al. Tumor suppressor p53 and its homologue p73alpha affect cell migration. 2003 |
| 35. A M Stark et al. p53, mdm2, EGFR, and msh2 expression in paired initial and recurrent glioblastoma multiforme. 2003 |
| 36. Weihua Qiu et al. Down-regulation of growth arrest DNA damage-inducible gene 45beta expression is associated with human hepatocellular carcinoma. 2003 |
| 37. Dmitri Wiederschain et al. Molecular basis of p53 functional inactivation by the leukemic protein MLL-ELL. 2003 |
| 38. Sonia Rocha et al. p53 represses cyclin D1 transcription through down regulation of Bcl-3 and inducing increased association of the p52 NF-kappaB subunit with histone deacetylase 1. 2003 |
| 39. Igal Louria-Hayon et al. The promyelocytic leukemia protein protects p53 from Mdm2-mediated inhibition and degradation. 2003 |
| 40. Krystyna Mazan-Mamczarz et al. RNA-binding protein HuR enhances p53 translation in response to ultraviolet light irradiation. 2003 |
| 41. Maoxiang Li et al. The phosphatase MKP1 is a transcriptional target of p53 involved in cell cycle regulation. 2003 |
| 42. Timothy F Burns et al. Silencing of the novel p53 target gene Snk/Plk2 leads to mitotic catastrophe in paclitaxel (taxol)-exposed cells. 2003 |
| 43. Gina Fusaro et al. Prohibitin induces the transcriptional activity of p53 and is exported from the nucleus upon apoptotic signaling. 2003 |
| 44. Stefanie Galbán et al. Influence of the RNA-binding protein HuR in pVHL-regulated p53 expression in renal carcinoma cells. 2003 |
| 45. Heng-Yin Yang et al. 14-3-3 sigma positively regulates p53 and suppresses tumor growth. 2003 |
| 46. Kentaro Kishi et al. Reduced MLH1 expression after chemotherapy is an indicator for poor prognosis in esophageal cancers. 2003 |
| 47. N J Trudgill et al. Cell cycle regulation in patients with intestinal metaplasia at the gastro-oesophageal junction. 2003 |
| 48. Hariklia Gakiopoulou et al. Tissue inhibitor of metalloproteinase-2 as a multifunctional molecule of which the expression is associated with adverse prognosis of patients with urothelial bladder carcinomas. 2003 |
| 49. Pere Puig et al. p73 Expression in human normal and tumor tissues: loss of p73alpha expression is associated with tumor progression in bladder cancer. 2003 |
| 50. Shinobu Honda et al. Activation of m-calpain is required for chromosome alignment on the metaphase plate during mitosis. 2004 |
| 51. Jian-Liu Wang et al. Predictive significance of the alterations of p16INK4A, p14ARF, p53, and proliferating cell nuclear antigen expression in the progression of cervical cancer. 2004 |
| 52. Sunil R Lakhani et al. Pathology of ovarian cancers in BRCA1 and BRCA2 carriers. 2004 |
| 53. Zhihui Feng et al. DNA damage induces p53-dependent BRCA1 nuclear export. 2004 |
| 54. Julien Mazieres et al. Loss of RhoB expression in human lung cancer progression. 2004 |
| 55. Antonio Marchini et al. The short stature homeodomain protein SHOX induces cellular growth arrest and apoptosis and is expressed in human growth plate chondrocytes. 2004 |
| 56. Sung-Kwon Moon et al. Disialoganglioside (GD3) synthase gene expression suppresses vascular smooth muscle cell responses via the inhibition of ERK1/2 phosphorylation, cell cycle progression, and matrix metalloproteinase-9 expression. 2004 |
| 57. VĂ©ronique Gire et al. DNA damage checkpoint kinase Chk2 triggers replicative senescence. 2004 |
| 58. Evgenia K Mikaelsdottir et al. The Icelandic founder mutation BRCA2 999del5: analysis of expression. 2004 |
| 59. Jian-Zhong Qin et al. p53-independent NOXA induction overcomes apoptotic resistance of malignant melanomas. 2004 |
| 60. Barbara I Oberschmid et al. Distinct secreted Frizzled receptor protein 1 staining pattern in patients with hyperplastic polyposis coli syndrome. 2004 |
| 61. Joshua Silverman et al. Human Rif1, ortholog of a yeast telomeric protein, is regulated by ATM and 53BP1 and functions in the S-phase checkpoint. 2004 |
| 62. Soo-Jung Park et al. Taxol induces caspase-10-dependent apoptosis. 2004 |
| 63. Paul A Jowsey et al. Human PTIP facilitates ATM-mediated activation of p53 and promotes cellular resistance to ionizing radiation. 2004 |
| 64. Wenrui Duan et al. Expression of Pirh2, a newly identified ubiquitin protein ligase, in lung cancer. 2004 |
| 65. Masanori Terai et al. Immortalization of human fetal cells: the life span of umbilical cord blood-derived cells can be prolonged without manipulating p16INK4a/RB braking pathway. 2005 |
| 66. Takayuki Hanamoto et al. Identification of protein kinase A catalytic subunit beta as a novel binding partner of p73 and regulation of p73 function. 2005 |
| 67. Gita Ohlsson et al. Loss of expression of the adipocyte-type fatty acid-binding protein (A-FABP) is associated with progression of human urothelial carcinomas. 2005 |
| 68. Andrew V Samuelson et al. p400 is required for E1A to promote apoptosis. 2005 |
| 69. David Goldschneider et al. The neurogene BTG2TIS21/PC3 is transactivated by DeltaNp73alpha via p53 specifically in neuroblastoma cells. 2005 |
| 70. Mark W Jackson et al. p130/p107/p105Rb-dependent transcriptional repression during DNA-damage-induced cell-cycle exit at G2. 2005 |
| 71. Xiao-Dong Zhou et al. Expression of cellular FLICE-inhibitory protein and its association with p53 mutation in colon cancer. 2005 |
| 72. Lindsey D Mayo et al. Phosphorylation of human p53 at serine 46 determines promoter selection and whether apoptosis is attenuated or amplified. 2005 |
| 73. Tetsuo Mashima et al. p53-defective tumors with a functional apoptosome-mediated pathway: a new therapeutic target. 2005 |
| 74. Ching-Hao Li et al. Chloramphenicol-induced mitochondrial stress increases p21 expression and prevents cell apoptosis through a p21-dependent pathway. 2005 |
| 75. Armando Rivera et al. The p53-induced gene-6 (proline oxidase) mediates apoptosis through a calcineurin-dependent pathway. 2005 |
| 76. Andrea Mueller et al. The calcium-binding protein S100A2 interacts with p53 and modulates its transcriptional activity. 2005 |
| 77. Yuichi J Machida et al. Acute reduction of an origin recognition complex (ORC) subunit in human cells reveals a requirement of ORC for Cdk2 activation. 2005 |
| 78. Michael Uhlin et al. Regulation of lck degradation and refractory state in CD8+ cytotoxic T lymphocytes. 2005 |
| 79. Jean-François Lavoie et al. TrkA induces apoptosis of neuroblastoma cells and does so via a p53-dependent mechanism. 2005 |
| 80. Shashirekha Shetty et al. Transcription factor NF-kappaB differentially regulates death receptor 5 expression involving histone deacetylase 1. 2005 |
| 81. Noriko Shirata et al. Activation of ataxia telangiectasia-mutated DNA damage checkpoint signal transduction elicited by herpes simplex virus infection. 2005 |
| 82. Hideshi Ishii et al. Frag1, a homolog of alternative replication factor C subunits, links replication stress surveillance with apoptosis. 2005 |
| 83. Vaneeta Marwaha et al. T-oligo treatment decreases constitutive and UVB-induced COX-2 levels through p53- and NFkappaB-dependent repression of the COX-2 promoter. 2005 |
| 84. Anja Duursma et al. p53-Dependent regulation of Cdc6 protein stability controls cellular proliferation. 2005 |
| 85. Roman Kulikov et al. Glycogen synthase kinase 3-dependent phosphorylation of Mdm2 regulates p53 abundance. 2005 |
| 86. Sylwia Ammoun et al. G-protein-coupled OX1 orexin/hcrtr-1 hypocretin receptors induce caspase-dependent and -independent cell death through p38 mitogen-/stress-activated protein kinase. 2006 |
| 87. Jianwei Ren et al. FAT10 plays a role in the regulation of chromosomal stability. 2006 |
| 88. Sylvia M Major et al. AbMiner: a bioinformatic resource on available monoclonal antibodies and corresponding gene identifiers for genomic, proteomic, and immunologic studies. 2006 |
| 89. Mariko Tomita et al. Inhibition of constitutively active Jak-Stat pathway suppresses cell growth of human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells. 2006 |
| 90. Daniela Pasquali et al. The endocrine-gland-derived vascular endothelial growth factor (EG-VEGF)/prokineticin 1 and 2 and receptor expression in human prostate: Up-regulation of EG-VEGF/prokineticin 1 with malignancy. 2006 |
| 91. Pabbisetty Sudheer Kumar et al. Differential expression and role of p21cip/waf1 and p27kip1 in TNF-alpha-induced inhibition of proliferation in human glioma cells. 2007 |